Invasion of prostatic adenocarcinoma into the seminal vesicles (SV) is generally accepted as an index of poor prognosis. The pre-operative identi®cation of SV invasion is an important element in staging since it may alter subsequent treatment decisions. We studied the possibility of diagnosing SV invasion with two biopsies from the junction between the prostate and seminal vesicles. Also we studied the correlation of several prognostic factors with the risk of clinical stage T 1,2,3 prostate cancer patients of having cancer growth into the seminal vesicles.
Introduction
There has been an increase in the referral of men for diagnosis or exclusion of prostate cancer to urological services. This is due to the growing awareness of prostatic disease and the prevalence of prostate cancer in men. Simultaneously, prostate-speci®c antigen (PSA) assays have become widely available and are used increasingly in primary care for the purpose of early detection. As a result, prostate cancer is the most frequently diagnosed malignancy among men in the USA, 1 and it is second in frequency in Europe. 2 Consequently more clinically localized tumors, with the greatest potential for cure, are being identi®ed. 3 Radical prostatectomy is an effective therapy for patients with organ-con®ned disease. However, despite the enhanced detection of these potentially organ-con®ned tumors, many patients have extracapsular disease Ð 27 ± 63%, at the time of radical prostatectomy. This major problem of clinical understaging is documented in several reports 4 ± 13 (not all studies are cited). The high percentage of patients with extracapsular extension and positive margins has generated efforts to enhance early detection, improve staging and, as a consequence, improve selection for therapy and hence improve prognosis for prostate cancer patients.
Capsular perforation and seminal vesicle (SV) invasion are unfavorable prognostic factors in prostate cancer. 7,14 ± 17 Both of these pathological ®ndings are associated with a high likelihood of local recurrence and increased mortality compared with organ-con®ned cancer. 16, 18, 19 Studies have shown SV invasion in 20 ± 26% of radical prostatectomy specimens. 15, 18, 19 Unfortunately, this evidence is only available after pathological examination of the radical prostatectomy specimen.
In 1990 Villers et al reported the mechanism of tumor spread into the seminal vesicles: in 46 of 47 cases of SV invasion, the tumor spread directly from the mid base of the prostate along and between the ejaculatory ducts. 18 Transrectal ultrasound-guided biopsies of the seminal vesicles may provide important diagnostic and staging information in select clinical situations. 14,20 ± 23 Using traditional investigational tools (PSA, digital rectal exam (DRE), transrectal ultrasound (TRUS), systematic prostate biopsies or pre-operative histological grading), the ability of the urologist to predict organ-con®ned disease appears to be not much better than a¯ip of the coin. 24 Hence there is a considerable risk of understaging and hence overtreatment. The adverse effects such as postoperative morbidity, the mortality of radical prostatectomy, albeit low, and the costs must be considered.
To decrease the risk of overtreatment, a comparison was made between these traditional parameters and the performance of PSA density (PSAD the ratio of serum PSA to the size of the prostate), SV biopsies and the measurement in serum of the free-to-total (f/t) PSA ratio. The latter, the f/t PSA ratio, is currently being evaluated as a means to improve the speci®city of PSA. 25, 26 It was demonstrated that a lower f/t PSA ratio is associated with more adverse pathologic features. 27 We investigated whether the f/t PSA ratio could enhance prediction of extraprostatic spread of prostate cancer, particularly in the seminal vesicles.
Patients and methods
A total of 138 consecutive patients referred for prostate evaluation (range 48 ± 94 y old, mean age 71.4, median 70.5) were investigated. The following criteria were used to trigger prostate biopsies: (1) DRE suggestive of cancer; (2) elevated PSA level ( b 4.0 mg/l); (3) TRUS abnormalities; (4) abnormal PSAD (a value of b 0.15 was judged abnormal); (5) f/t PSA ratio`25%.
The population in this study does not represent a screening population. None of the patients received any hormonal therapy prior to the sampling of blood specimens. Serum PSA, free PSA and the proportion of free-tototal PSA (DPC-IMMULTE assay) were measured in all patients before any prostate manipulation (DRE, TRUS).
The volume of the prostate was estimated by transrectal ultrasound by measuring the maximal height (H) and width (W) obtained from the transverse images. Maximal length (L) was obtained from the longitudinal image. The volume was calculated as follows: H 6 W 6 L 6 p/6. PSAD, a parameter introduced by Benson et al to enhance early detection of prostate cancer, is de®ned as the serum PSA value divided by the volume of the entire gland. 28 The PSAD was calculated during ultrasound. Transrectal ultrasound-guided biopsies were performed in the sagittal plane with a 7.5 MHz sector scanner ®tted with a biopsy guide using an 18 gauge needle driven by a spring-loaded biopsy gun. All the TRUS-guided biopsies were performed by one urologist using a Kretz 360 machine with a 7.5 ± 10 MHz sector scanner. A suspicious lesion was one that appeared hypoechoic relative to the echogenic pattern of the peripheral zone of the normal prostate. When a suspicious lesion was seen, guided biopsies were taken; when no speci®c lesion was detected, the gland was biopsied systematically according to the method of Stamey. 29 In the longitudinal plane an additional SV biopsy was obtained from each side at the junction of the seminal vesicle and the prostate. 30 Figure 1 shows in a diagram the correct placement of the needle just cephalad of the base of the prostate. The exact placement of the needle for biopsy is necessary in order to avoid the base of the prostate and the distal seminal vesicle. Any SV biopsy judged grossly to be less than one-third of the needle channel was considered of insuf®cient length and was followed by a second SV sample out of that area. All patients received prophylactic antibiotics (O¯oxacine, 400 mg) orally 1 h before biopsy and 24 h afterwards. Biopsy specimens from each site in addition to the usual prostatic biopsies were processed separately. Each core was ®xed in 10% formalin embedded in paraf®n, sectioned longitudinally, stained with hematoxylin and eosin, and examined by the pathologist for SV involvement at the base. SV invasion was de®ned as invasion of the muscular wall of the seminal vesicle as described by Epstein et al. 16 Patients with SV involvement were considered to have extracapsular extension by de®nition.
The biopsy ®ndings were reported by the pathologist using WHO grading as either well differentiated (G1), moderately differentiated (G2), or poorly differentiated (G3). 31 Preoperative clinical stages were assigned based upon the biopsy results according to the TNM classi®ca-tion. 32 The SV biopsy was well tolerated and there were no prostatic or SV infections or long-term complications. In case of stage migration, because of a positive SV biopsy radical prostatectomy was no longer advocated. Five patients who underwent a pelvic lymphadenectomy followed by a radical retropubic prostatectomy served as control patients. The rest of the patients with negative seminal vesicle biopsies did not undergo a radical retropubic prostatectomy for several reasons (age, comorbidity etc).
Statistical methods
Statistical analysis was performed using computer software and applying Student's t-test to the natural data and the chi-square test to the categorical data. A P-valuè 0.05 was considered statistically signi®cant. The relative effectiveness of the diagnostic tests was illustrated by plotting the true positive (sensitivity) vs false positive (1-speci®city) ratios in receiver operating characteristic curves (ROC). ROC analysis is particularly useful for comparing two diagnostic tests when the cut-off point for a positive or negative test has not been clearly de®ned. Areas under the receiver operating characteristic curves (AUC) were compared by a non-parametric method as described by Hanley and McNeil. 33 
Results
The overall accuracy rate for obtaining SV tissue in the biopsies from 138 patients was 91% : 92% for the left SV and 89% for the right SV. Of the 138 patients on whom biopsies were performed, 83 (60%) had carcinoma of the prostate and 55 (40%) were negative for malignancy. In the ®ve patients who underwent radical prostatectomy, investigation of the prostatectomy specimens showed no extraprostatic involvement of the seminal vesicles.
Seminal vesicle biopsies
In the biopsies of the 83 patients with prostate cancer a positive SV biopsy was found in 37 patients (44.6%). PSA values of 0.0 ± 4.0 mg/l, 4.1 ± 10.0 mg/l, 10.1 ± 20 mg/l and more than 20 mg/l were used to assess the risk of a positive SV biopsy. Table 1 Figure  2b ). PSA and PSAD were more speci®c and had a higher positive predictive value than each of the other tests for the whole population of 138 patients. Table 2 shows f/t PSA ratios for 55 of the 83 patients with prostate carcinoma, in four categories (`10%, 10 ± 15%, 15 ± 20%, b 20%). The f/t PSA ratios were not measured in the other 28 patients. There was no signi®-cant correlation (P 0.588) of the percentage of f/t PSA with SV invasion in the whole group (negative SV: mean f/t ratio 10.4, median 9.0; and positive SV: mean f/t ratio 9.1, median 9.0; see also Figure 2c) .
The difference between vesicula seminalis invasion and histological tumor differentiation grade was statistically signi®cant (P 0.001). Table 3 shows the interrelationship between seminal vesicle invasion and tumor grade, suggesting a higher invasion rate with de-differentiation. Table 4 gives the distribution of the clinical estimation of tumor stage and seminal vesicle biopsy results and shows a higher invasion rate with advancing clinical stage (P 0.0005).
Overall PSAD and PSA appeared to be the most important predictors of seminal vesicle involvement, whereas the relationship between seminal vesicle involvement and f/t PSA ratio was not signi®cant (P 0.588). The areas under the ROC curve for the PSAD and for the PSA were alike (0.85; Figure 3 ).
Discussion
With the limitations of current pre-operative staging studies there is a suboptimal prediction of pathologic stage for the individual patient. 34 ± 38 It is therefore essential to make a distinction between patients with organcon®ned vs margin-positive disease to plan subsequent therapy.
Unfortunately, digital rectal examination (DRE) and classical imaging techniques such as transrectal ultrasonography (TRUS), computed tomography (CT) and magnetic resonance imaging (MRI) cannot accurately stage prostate cancer Ð 12 ± 30% of clinical T 1 cancers and 30 ± 60% of clinical T 2 cancers are in fact pT 3 . 34, 39, 40 The detection of seminal vesicle involvement has been demonstrated in several studies that examined retrospectively the results of radical prostatectomy in patients with clinically con®ned disease. In a study by Terris et al the seminal vesicle positive rate was 13.8%. 22 Villers et al reported pathological seminal vesicle involvement after radical prostatectomy in 19% of 241 patients with clinical stage T 1 /T 2 . 18 Furthermore, he showed that the frequency of seminal vesicle invasion increased with tumor volume, in line with our ®ndings (Table 4 ). The present study had a 44% rate of positive seminal vesicle biopsies. The differences between our study and the previous studies are mainly due to a higher stage disease. Seminal vesicle invasion has been regarded as an index of poor prognosis. 7,17,19,41 ± 43 Several studies have presented evidence that this prognostic association relates to a strong correlation between seminal vesicle involvement and the presence of lymph node metastases. 44 ± 46 To improve clinical assessment before a therapy decision is made, a less invasive method was needed to detect seminal vesicle involvement by the use of transrectal ultrasound-guided biopsies. 47 In this study a comparison was made between the traditional parameters (PSA, TRUS, histological grading from the biopsy specimen) and PSAD, the f/t PSA ratio and seminal vesicle biopsy. TRUS and biopsies were performed in patients in whom there was a suspicion of prostate cancer on the basis of PSA level, abnormal PSAD, a low f/t PSA ratio or DRE ®ndings. The overall accuracy rate to obtain seminal vesicle tissue in the biopsies was 91%, which is comparable to the 90 ± 92% rate reported by others. 22, 30, 48 Partin et al used digital rectal examination, pre-operative Gleason score and serum PSA level to predict organ con®nement status and ranked them in a series of probability nomograms. 12 Among 667 men with clinically localized disease, 56% had pathologically organ-con®ned disease. We followed this regime and added for the subgroup clinical stage T 1 ± 3 prostate cancer the following items: PSAD, the f/t PSA ratio and the results of seminal vesicle biopsies to study the possible improvement in staging prostate cancer. For this part of the study six patients with T 4 disease were excluded and patients with clinical estimated tumor, stage T 1,2 and T 3 M0 tumors were included. Including patients with extraprostatic extension (and high PSA values) will skew the data and as a consequence statistically signi®cant differences will arise in the variables tested. However, in this study statistically signi®cant differences were found between the cancer patients with and without seminal vesicle in®ltration with respect to PSA (P`0.0005) and PSAD (P`0.0005). For histological grade (P`0.001) there was a less signi®cant correlation. Figure 3 shows an ROC curve for these parameters with the AUC respectively. Some investigators recently showed that the f/t PSA ratio could not predict extraprostatic spread of prostatic cancer. 49 ± 51 We have shown that the f/t PSA ratio did not predict whether adenocarcinoma had spread into the seminal vesicles in the whole group of prostate cancer patients (P 0.588). This has not been reported by others to date. Our study showed that additional information can be gained about the extent of cancer in the seminal vesicles using systemic needle SV biopsy and the correlation with the usual parameters, including PSAD and PSA. The goal of this combination is to stage patients more accurately when apparently localized disease is suspected.
Conclusions
The accurate pre-operative staging of prostate cancer is a major issue, due to the dif®culty in assessing local spread of the disease. Despite technical improvement in imaging techniques and the use of molecular biology, the exact determination of the extracapsular extent of the tumor before surgery is not yet possible. The value of a single factor can only clearly be assessed in multivariate analysis.
In prostate cancer serum PSA, PSAD, clinical stage and histological grading system are useful to select patients for systemic seminal vesicle biopsies. The free-to-total PSA ratio did not predict whether adenocarcinoma had spread into the seminal vesicles. Involvement of the seminal vesicle is of prognostic signi®cance 52 and in men with T 1 or T 2 prostate cancer it is the most signi®cant predictor of pelvic lymph node metastasis. 46 Biopsies of the seminal vesicle just cephalad to the junction of the seminal vesicle and the prostate is an adjunct to staging with high ef®cacy and low morbidity. Our study showed that the predictors of seminal vesicle invasion as (biopsy) tumor grade, PSAD, PSA and clinical stage are the same as the conventional predictors of pathology at radical prostatectomy. Given the considerable economic impact of the evaluation and management on the health care system for patients with prostate cancer, cost-effectiveness studies are needed. Figure 3 Receiver operating characteristic curve analysis for PSA density, PSA and free-to-total PSA ratio in prostate cancer with seminal vesicle invasion. In a comparison between the area under the curve of PSA density (PSAD) (0.85), PSA (0.85) and free-to-total PSA ratio (0.66), PSAD and serum PSA levels are signi®cantly better predictors for the presence of prostate cancer invasion in the seminal vesicles than serum free-to-total PSA ratio (P`0.0005).
